Response gets good response from creditors and FDA
This article was originally published in Clinica
Executive Summary
Canadian diagnostics company Response Biomedical received a double boost last week when eligible creditors voted unanimously to accept the company's proposal filed under the Bankruptcy and Insolvency Act with the British Columbia Supreme Court. In addition, the Vancouver, British Columbia company says that the FDA has indicated that the company's PMA for its RAMP myoglobin assay and RAMP reader will be removed from the "on-hold" status.